IRIS
MAFFEZZINI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.591
AS - Asia 727
NA - Nord America 578
Continente sconosciuto - Info sul continente non disponibili 65
SA - Sud America 54
AF - Africa 14
OC - Oceania 1
Totale 8.030
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.487
US - Stati Uniti d'America 543
SG - Singapore 329
CN - Cina 145
BD - Bangladesh 118
VN - Vietnam 71
FR - Francia 55
BR - Brasile 27
HK - Hong Kong 20
DE - Germania 15
AR - Argentina 13
MX - Messico 12
JP - Giappone 10
CA - Canada 9
GB - Regno Unito 8
ID - Indonesia 8
CO - Colombia 6
IN - India 6
IQ - Iraq 6
NL - Olanda 5
CH - Svizzera 4
IE - Irlanda 3
JM - Giamaica 3
KZ - Kazakistan 3
RU - Federazione Russa 3
VE - Venezuela 3
CR - Costa Rica 2
EC - Ecuador 2
ES - Italia 2
HN - Honduras 2
MY - Malesia 2
NA - Namibia 2
NI - Nicaragua 2
SA - Arabia Saudita 2
SE - Svezia 2
ZA - Sudafrica 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
GT - Guatemala 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MR - Mauritania 1
NP - Nepal 1
PE - Perù 1
PL - Polonia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SO - Somalia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 7.965
Salva come PNG Salva come JPEG
Città #
Genova 3.863
Genoa 1.340
Rapallo 729
Vado Ligure 435
San Jose 189
Singapore 172
Ashburn 93
Lauterbourg 52
Bordighera 50
Ho Chi Minh City 24
New York 24
Beijing 21
Santa Clara 19
Hong Kong 18
Frankfurt am Main 12
Hanoi 12
Rome 11
Buffalo 10
Los Angeles 8
Mexico City 8
Tokyo 8
Houston 6
Milan 6
Amsterdam 5
Atlanta 5
Dallas 5
Biên Hòa 4
Haiphong 4
Philadelphia 4
San Antonio 4
São Paulo 4
Denver 3
Dublin 3
Hải Dương 3
Indpls 3
Minneapolis 3
Semarang 3
Baltimore 2
Bogotá 2
Bologna 2
Brasília 2
Brooklyn 2
Buenos Aires 2
Bắc Ninh 2
Caracas 2
Charlotte 2
Chicago 2
Conyers 2
Corpus Christi 2
Florence 2
Fort Myers 2
Garland 2
Guayaquil 2
Gurugram 2
Hays 2
Homewood 2
Jackson 2
Lausanne 2
Lexington 2
London 2
Louisville 2
Managua 2
Mandeville 2
Naples 2
Newark 2
Nuremberg 2
Orem 2
Ottawa 2
Posadas 2
Riyadh 2
Salerno 2
San José 2
Shanghai 2
Stockholm 2
Turin 2
Van Nuys 2
Verona 2
Windhoek 2
Woodbridge 2
Abidjan 1
Aci Castello 1
Afragola 1
Al Diwaniyah 1
Al Hillah 1
Albuquerque 1
Alexandria 1
Allentown 1
Almaty 1
Amesbury 1
Astana 1
Athens 1
Attleboro 1
Austin 1
Avella 1
Baghdad 1
Baku 1
Bandung 1
Barranquilla 1
Baton Rouge 1
Beggs 1
Totale 7.268
Salva come PNG Salva come JPEG
Nome #
Large bladder diverticula: a comparison between laparoscopic excision and endoscopic fulguration 200
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry. 186
Systemic absorption and pharmacokinetics of single-dose early intravesical mitomycin C after transurethral resection of non-muscle invasive bladder cancer. 179
Bladder cell culture on small intestinal submucosa as bioscaffold: Experimental study on engineered urothelial grafts 179
Pre-operative assessment of cancer in the elderly (PACE): A comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery 169
Developing a five-step training model for transperineal prostate biopsies in a naïve residents’ group: a prospective observational randomised study of two different techniques 169
A Multimodal Perioperative Plan for Radical Cystectomy and Urinary Intestinal Diversion: Effects, Limits and Complications of Early Artificial Nutrition 168
Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study. 168
Incidence and survival of rare urogenital cancers in Europe. 165
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. 163
Evaluation of complications and results in a contemporary series of 300 consecutive radical retropubic prostatectomies with the anatomic approach at a single institution 162
Age Is Predictive of Immediate Postoperative Urinary Continence after Radical Retropubic Prostatectomy 162
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help - A SIOG surgical task force prospective study. 160
Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease 159
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation 157
Estimates of prostate cancer burden in Italy. 156
A prognostic model including pre- and postsurgical variables to enhance risk stratification of primary mediastinal nonseminomatous germ cell tumors: the 27-year experience of a referral center. 155
"What if…": decisional regret in patients who discontinued active surveillance 151
A Simple Mathematical Approach to Calculate Blood Loss in Radical Prostatectomy 151
Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus 149
Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral Center. 147
Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy. 146
Prognostic Significance of Fluorescent In Situ Hybridisation in the Follow-up of Non-muscle-invasive Bladder Cancer 141
Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancer. 140
Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma. 140
Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch 140
Multimodal Perioperative Plan for Radical Cystectomy and Intestinal Urinary Diversion. I. Effect on Recovery of Intestinal Function and Occurrence of Complications 136
Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder 136
Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer 135
Postchemotherapy lymphadenectomy in patients with metastatic urothelial carcinoma: long-term efficacy and implications for trial design 134
Active surveillance in young patients with prostate cancer: the unanswered question 133
The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis. 132
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes. 126
For wider acceptance of radical cystectomy and extended pelvic lymphadenectomy 123
Feeding Hungry Patients, Even Those Well Nourished 121
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. 120
The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcome. 120
Editorial comment on: long-term rates of undetectable psa with initial observation and delayed salvage radiotherapy after radical prostatectomy 119
Phase I-II Trial of Weekly Bicalutamide in Men with Elevated Prostate-Specific Antigen and Negative Prostate Biopsies 117
Osteopontin plasma levels does not detect prostate cancer in patientsreferred for diagnostic biopsy 116
Short-Schedule Intravesical Gemcitabine with Ablative Intent in Recurrent Ta–T1, G1–G2, Low- or Intermediate-Risk, Transitional Cell Carcinoma of the Bladder 115
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation. 115
Systemic Absorption and Pharmacokinetics of Single-dose Intravesical Gemcitabine After Transurethral Resection of the Bladder in Non-muscle-invasive Bladder Cancer 114
Re: Vincent Cloutier, Umberto Capitanio, Laurent Zini, et al. Thirty-Day Mortality after Nephrectomy: Clinical Implications for Informed Consent. Eur Urol 2009;56:998-1005 111
Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progression. 111
Focal therapy in urology: kidney cancer 110
Re: Trends in hospital volume and operative mortality for high-risk surgery 110
TC Incidence Increasing: Spread the Word 109
Prostatic metastases from testicular nonseminomatous germ cell cancer: two case reports and a review of the literature. 109
Peri-operative management of ablative and reconstructive surgery for invasive bladder cancer in the elderly. 108
Paraganglioma of the prostate in a young adult 107
Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer 105
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial. 102
High-Risk Prostate Cancer is Worth Further Risk Stratification 100
The magnitude of the problem and the burden of physicians and patient decisions 98
Systemic Absorption and Pharmacokinetics of Single-Dose, Post-TURB (Trans-Urethral Resection of Bladder), Intravesical Gemcitabine, in Non-Muscle Invasive Bladder Cancer. 98
Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability. 96
Bladder Cancer 94
Urinary Diversion and Morbidity After Radical Cystectomy for Bladder Cancer 75
The survival of patients with bone metastases from renal cell carcinoma 64
Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading. 49
Totale 8.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.085
article - articoli 26.716
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 369
Totale 54.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022818 30 83 67 71 23 78 50 162 65 64 41 84
2022/2023856 74 47 3 96 102 146 0 99 142 3 138 6
2023/2024323 22 42 6 39 16 52 14 51 15 11 24 31
2024/2025990 5 84 23 58 150 143 64 152 49 61 110 91
2025/20261.786 170 14 109 106 268 197 278 62 83 119 188 192
2026/2027147 147 0 0 0 0 0 0 0 0 0 0 0
Totale 8.030